Foncer Pharma Private Limited, a active private limited company, was established on 22 July 2016 in Nagpur, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74999MH2016PTC283986. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 38 professional, Its leadership includes Parag Balkrishna Kumbalkar (Additional Director), Swapnilkumar Narayan Deotalu (Director). Past directors included Chandrakant Wamanrao Kumbhare, Savita Dattatreya Kunte, Swapnilkumar Narayan Deotalu. It holds ₹2.10 Cr open charges and ₹1.51 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 19 Flat No G1 C/O Savita Dattatray Kunte Sadguru Apartment Shashtri Layout, Nagpur, Maharashtra, 440022.
U74999MH2016PTC283986
283986
22 July 2016
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Foncer Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parag Balkrishna Kumbalkar | Additional Director | 30 Apr 2019 | Current |
| Swapnilkumar Narayan Deotalu | Director | 11 May 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Jun 2018 | Past |
| Pramod Abcsdd | Director | 02 May 2019 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Foncer Pharma Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 213.48% increase. The company also saw a substantial improvement in profitability, with a 37.2% increase in profit. The company's net worth Soared by an impressive increase of 83.81%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Foncer Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹21,000,000.00
₹15,095,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Sep 2023 | Others | ₹2.10 Cr | Open |
| 13 Mar 2023 | Others | ₹1.20 Cr | Satisfied |
| 17 Jun 2020 | Canara Bank | ₹0.30 M | Satisfied |
| 11 Sep 2018 | Canara Bank | ₹2.80 M | Satisfied |
Explore comprehensive loan charge details -
Foncer Pharma has a workforce of 38 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Foncer Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Foncer Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 21.00 M registered on 18 Sep 2023 with Charge ID 100802160 was modified on 30 Nov 2024. was documented.
The activity A charge registered on 13 Mar 2023 via Charge ID 100688630 with Others was fully satisfied on 25 Oct 2024. was completed.
Foncer Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Foncer Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
A charge with Others amounted to Rs. 21.00 M with Charge ID 100802160 was registered on 18 Sep 2023. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 12.00 M with Charge ID 100688630 was registered on 13 Mar 2023. was documented.
The CIN of Foncer Pharma Private Limited is U74999MH2016PTC283986.
Foncer Pharma Private Limited is headquartered at 19 Flat No G1 C/O Savita Dattatray Kunte Sadguru Apartment Shashtri Layout, Nagpur, Maharashtra, 440022.
Foncer Pharma Private Limited was incorporated on 22 July 2016.
The current directors of Foncer Pharma Private Limited are
The primary industry of Foncer Pharma Private Limited is Trade.
Foncer Pharma Private Limited is unlisted.
The authorized capital of Foncer Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Foncer Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX